Abstract:AIM:Chemotherapy-induced reactive oxygen species (ROS) not only contribute to apoptosis, but also trigger autophagy. Since autophagy is reported to protect cancer cells from apoptosis, this weakens the therapeutic effect of chemotherapy. This study aimed at identifying the key molecules that determine the cellular response to ROS and, therefore, provide better strategies to increase chemotherapeutic efficiency.RESULTS:Increasing concentrations of N-(4-hydroxyphenyl) retinamide (4-HPR)-treatment pushed autophagy down to apoptosis in a dose-dependent manner, and 4-HPR-induced ROS contribute to this process. Since we found that ASK1-regulated JNK1 and p38 are responsible for 4-HPR-induced autophagy and apoptosis, respectively, we further utilized co-immunoprecipitation followed by liquid chromatography-tandem mass spectrometry analysis to identify proteins that specifically bind to ASK1 under different oxidative states. Of note, DJ-1, a crucial antioxidant protein, was identified. Interestingly, DJ-1 functions as a redox sensor that senses ROS levels and determines the cellular response to 4-HPR: Under mild oxidative stress, moderate oxidation of DJ-1 is recruited to inhibit the activity of ASK1 and maintain cell viability by activating autophagy; under a lethal level of oxidative stress, excessive oxidized DJ-1 dissociates from ASK1 and activates it, thereby initiating p38 activation and enabling the cells to commit to apoptosis. Moreover, the depletion of DJ-1 increases the sensitivity of tumor cells to 4-HPR both in vitro and in vivo.INNOVATION:Our results reveal that the different oxidation states of DJ-1 function as a cellular redox sensor of ROS caused by 4-HPR and determine the cell fate of autophagy or apoptosis. Moreover, the results suggest that DJ-1 might be a potent therapeutic target for cancer treatment.CONCLUSION:ROS-mediated changes in the oxidation state of DJ-1 are involved in 4-HPR's effect on pushing autophagy down to apoptosis. Consequently, this change mediates ASK1 activation by regulating DJ-1-ASK1 complex formation and determines the cell fate of autophagy or apoptosis.

Redox Signaling: Potential Arbitrator of Autophagy and Apoptosis in Therapeutic Response

Redox Regulation of Autophagy in Cancer: Mechanism, Prevention and Therapy

Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis

Reactive Oxygen Species Regulation of Autophagy in Cancer: Implications for Cancer Treatment.

Redox Regulation of Cell Survival

Recent Advances in Cellular Signaling Interplay between Redox Metabolism and Autophagy Modulation in Cancer: An Overview of Molecular Mechanisms and Therapeutic Interventions

Redox control of the survival of healthy and diseased cells.

Redox balance and autophagy regulation in cancer progression and their therapeutic perspective

Reactive Oxygen Species as a Link between Antioxidant Pathways and Autophagy

Mitochondrial Redox Signaling And Tumor Progression

The double-edged roles of ROS in cancer prevention and therapy

Autophagy: A Crucial Moderator of Redox Balance, Inflammation, and Apoptosis in Lung Disease

Unravelling the relationship between macroautophagy and mitochondrial ROS in cancer therapy

Regulation of Autophagy in Hematological Malignancies: Role of Reactive Oxygen Species

Redox regulation and its emerging roles in cancer treatment

Oxidative cell death in cancer: mechanisms and therapeutic opportunities

The Oxidation States of DJ-1 Dictate the Cell Fate in Response to Oxidative Stress Triggered by 4-Hpr: Autophagy or Apoptosis?

ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway

Modulation of redox signal transduction pathways in the treatment of cancer

The Emerging Role of Oxidative Stress in Regulating Autophagy: Applications of Cancer Therapy.

Modulation of redox homeostasis: A strategy to overcome cancer drug resistance